Beyond Cancer™ Announces New Preclinical Data Presented at American Association for Cancer Research (AACR) Showing Ultra-High Concentration Nitric Oxide Therapy Anti-Tumor Effect

Apr 11, 2022 7:00am EDT

Beyond Cancer™ to Present Two Abstracts for Ultra-High Concentration Nitric Oxide Therapy at the 2022 AACR Annual Meeting

Mar 08, 2022 4:35pm EST

Beyond Air® Reports Financial Results for the Third Quarter of Fiscal Year 2022

Feb 10, 2022 4:05pm EST

Beyond Air® Announces Participation at Upcoming Investor Conferences in March 2022

Feb 08, 2022 8:00am EST

Beyond Air® Announces Two Appointments to Beyond Cancer™ Board of Directors

Feb 03, 2022 4:05pm EST

Beyond Air® Schedules Third Fiscal Quarter 2022 Financial Results Conference Call and Webcast

Jan 27, 2022 8:00am EST

Beyond Air® Provides Regulatory Update for LungFit® PH

Dec 09, 2021 8:30am EST

Beyond Air® Expands Leadership Team with the Appointment of Dr. Andrew Colin to Chief Medical Officer

Dec 01, 2021 8:00am EST

Beyond Air® Announces $30 Million of Committed Capital in Previously Reported Beyond Cancer™ Private Placement

Nov 18, 2021 4:05pm EST

Beyond Air® Reports Financial Results for the Second Quarter of Fiscal Year 2022

Nov 11, 2021 4:05pm EST